Catherine Smith, MD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, @UCSFCancer offers her overall impression on the changing FLT3 inhibition landscape in acute myeloid leukemia (AML).
Advertisement
Changing FLT3 Inhibition Landscape in AML @UCSFCancer
